P3 Health Partners (PIII) Net Income towards Common Stockholders (2021 - 2026)

P3 Health Partners (PIII) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$165.7 million in Q4 2025.

• Quarterly Net Income towards Common Stockholders fell 28.31% year-over-year to -$165.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$323.1 million (down 4.09% YoY) and the FY2025 annual result came in at -$323.1 million, down 4.09% from the prior year.
• Net Income towards Common Stockholders fell to -$165.7 million in Q4 2025, from -$69.5 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$10.6 million in Q1 2022 to a low of -$903.1 million in Q2 2022.
• A 5-year average of -$122.2 million and a median of -$46.9 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 2965.07% — and 2023, when it jumped 96.95%.
• Tracing PIII's Net Income towards Common Stockholders over 5 years: stood at -$26.9 million in 2021, then tumbled by 1881.19% to -$532.3 million in 2022, then surged by 87.02% to -$69.1 million in 2023, then sank by 86.88% to -$129.1 million in 2024, then retreated by 28.31% to -$165.7 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$165.7 million (Q4 2025), -$69.5 million (Q3 2025), and -$43.7 million (Q2 2025), per Business Quant data.